Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 05 2020
revised: 01 06 2020
accepted: 21 06 2020
pubmed: 29 8 2020
medline: 22 6 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Data regarding the possible relationship of insomnia and EDS with mortality are inconclusive. The aim of this study was to investigate the association between these sleep complaints and the risk of long-term (20 years) all-cause mortality in older adults. Between April 2000 and March 2001, 750 subjects aged 65 years and older, who resided in the seventh district of Udine, were recruited. Data on sociodemographic characteristics, past medical history, and pharmacological treatment were collected. Dementia was diagnosed using a comprehensive neurological and neuroradiological assessment. Older adults were interviewed by neuropsychologists trained in sleep disturbances in order to assess the presence of sleep complaints. Vital status was followed over 20 years until March 2020. Older male adults affected by insomnia and EDS were significantly more likely to die over the follow-up period. Indeed, males reporting poor sleep and daytime somnolence had a 60% and 48% higher chance of dying than subjects who were not affected by these sleep complaints, respectively. The HR was attenuated after adjusting for confounding variables among insomniacs, whereas that of somnolent men strengthened. Differently from men, insomnia and EDS did not have any impact on mortality in older women. In conclusion, older male adults affected by insomnia and EDS had a significant increased risk of mortality, which is independent of cancer, depression, dementia, cardiovascular diseases, and sleeping pill use.

Identifiants

pubmed: 32858331
pii: S1389-9457(20)30292-6
doi: 10.1016/j.sleep.2020.06.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-207

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

G Merlino (G)

Clinical Neurology, Udine University Hospital, Udine, Italy. Electronic address: giovanni.merlino@asufc.sanita.fvg.it.

S Lorenzut (S)

Neurology, Department of Neuroscience, Udine University Hospital, Udine, Italy.

G L Gigli (GL)

Clinical Neurology, Udine University Hospital, Udine, Italy; DMIF, University of Udine, Udine, Italy.

I Del Negro (I)

Clinical Neurology, Udine University Hospital, Udine, Italy.

Y Tereshko (Y)

Clinical Neurology, Udine University Hospital, Udine, Italy.

C Smeralda (C)

Clinical Neurology, Udine University Hospital, Udine, Italy.

A Piani (A)

Neurology, Department of Neuroscience, Udine University Hospital, Udine, Italy.

M Valente (M)

Clinical Neurology, Udine University Hospital, Udine, Italy; DAME, University of Udine, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH